Analyst Price Target is GBX 6,000
▲ +7,523.89% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Dr. Martens in the last 3 months. The average price target is GBX 6,000, with a high forecast of GBX 6,000 and a low forecast of GBX 6,000. The average price target represents a 7,523.89% upside from the last price of GBX 78.70.
Current Consensus is
Moderate Buy
The current consensus among 4 investment analysts is to moderate buy stock in Dr. Martens. This rating changed within the last month from a Hold consensus rating.
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.
Read More
